GEM 132

Gene Expression Modulation 132

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Dvorchik BH, Grindel JM, Ferdinandi ES. Retinal uptake, autoradiography and metabolic profiling of GEM (Rm) 132 in male Dutch belted rabbits and rhesus monkeys after a single intravitreal injection of 14C or 35S-GEM (Rm) 132. Pharm Res 1997 Nov; 14 Suppl.: 330
Google Scholar
Hybridon. Hybridon’s anti-CMV drug advances to phase I/III trials in France [press release]. PR Newswire [online]. 16 Jan 1997. Available from: URL: http://www.prnewswire.co.uk [Accessed 1999 Oct 28]
Field AK, Pari GS, Martin RR. GEM 132 — an antisense drug for the treatment of CMV. Int Antiviral News 1997 Dec; 5: 219–22
Google Scholar

GEM 132. Drugs R&D 2, 313–314 (1999). https://doi.org/10.2165/00126839-199902050-00007

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.